MiraKind will review your application once you take the eligibility survey to apply for a study. Once you have completed your survey, if you are eligible, you can directly order your KRAS-variant results, which we will share with a physician of your choice, for a fee of $129.  However, participation in a study is free if you do not want to receive your results.  At the completion of the study, we will conduct a webinar to communicate the research findings and answer questions from participants.

The greatest benefit to participation is knowing that you are helping to find answers that can ultimately save lives and prevent cancer.  If you also choose to learn your KRAS-variant status as part of the process of participating in a study, this knowledge may help you make healthcare decisions into the future. However, whether or not you choose to learn your KRAS-variant status, we welcome you to be part of the MiraKind community where you will have access to support, education, and cutting edge research on the KRAS-variant and other inherited genetic differences associated with cancer risk.

Joining a study is not a way to directly order your KRAS-variant results. However, you do have the option to obtain your individual results if you are eligible, through a physician of your choice for a discounted fee of $129, which covers the basic costs of processing the test.

If you're only interested in receiving your KRAS-variant results, you can directly order them here through our sister CLIA lab, MiraDx, for $159.

For study participants, results are available at a discounted rate of $129, also through MiraDx.

No! Participation in a study is free.

If you'd like to obtain your individual results, you may do so for a discounted fee of $129, which covers the basic costs of processing the test at our sister company, MiraDx's CLIA lab. MiraDx will send the results to your chosen physician.

After we receive your survey, we will mail you a consent form. Once the consent form is returned to us, you will receive a DNA collection kit in the mail from our sister CLIA lab, MiraDx.

After you perform a simple cheek swab, put your sample in the pre-paid envelope and mail it back to us.

MiraKind will analyze study participants' DNA samples to answer research question(s). Some of you may receive a follow-up study-specific questionnaire to help us gain a more understanding of your health history.

All study participants will have the opportunity to be among the first to learn about the research findings through a MiraKind webinar that will take place at the conclusion of each study.

Currently we have no studies for men to participate in, however you may subscribe to our newsletter here to hear about future studies.

If you participate in a study, your data will be used in that study and be kept strictly confidential. We will never share your data with others.

Yes, you are welcome to participate in as many studies as you wish, as long as you meet the study criteria.